title: Arterial embolization of unresectable hepatocellular carcinoma with use of microspheres, lipiodol, and cyanoacrylate.
abstract: We performed a retrospective analysis of 46 patients with histologically confirmed hepatocellular carcinoma (HCC) who were treated with transarterial embolization (TAE) of the hepatic arteries. To induce permanent embolization, microspheres (Embosphere; 100 to 700 micron) and a mixture of ethiodized oil (Lipiodol Ultrafluide) with cyanoacrylate (Glubran) was injected. A total of 106 TAE procedures were performed. Cumulative survival rates were calculated. No patient died during embolization or within the first 24 hours. Severe procedure-related complications were observed in 2 patients. At the time of analysis, 38 of 46 patients were alive. The 180-, 360-, 520-, and 700-day cumulative survival rates for the total study population were 80.6%, 70.7%, 70.7%, and 47.1%, respectively, with a median survival of 666 days. TAE with the use of microspheres and Lipiodol and cyanoacrylate for unresectable HCC is a feasible treatment modality. Bland embolization with the use of microspheres can be used in patients for whom chemoembolization is not desired.
authors.affiliation: Department of Angiography and Interventional Radiology, University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria. thomas.rand@meduniwien.ac.at
authors.forename: Thomas
authors.initials: T
authors.lastname: Rand
authors.forename: Christian
authors.initials: C
authors.lastname: Loewe
authors.forename: Maria
authors.initials: M
authors.lastname: Schoder
authors.forename: Maria Theresa
authors.initials: MT
authors.lastname: Schmook
authors.forename: Markus
authors.initials: M
authors.lastname: Peck-Radosavljevic
authors.forename: Joachim
authors.initials: J
authors.lastname: Kettenbach
authors.forename: Florian
authors.initials: F
authors.lastname: Wolf
authors.forename: Barbara
authors.initials: B
authors.lastname: Schneider
authors.forename: Johannes
authors.initials: J
authors.lastname: Lammer
mesh_terms: D000180:Acrylic Resins / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000628:therapy*; D003487:Cyanoacrylates / Q000627:therapeutic use*; D004621:Embolization, Therapeutic / Q000009:adverse effects / Q000379:methods*; D005240:Feasibility Studies; D005260:Female; D005471:Fluoroscopy; D005500:Follow-Up Studies; D005780:Gelatin / Q000627:therapeutic use*; D006499:Hepatic Artery; D006801:Humans; D007459:Iodized Oil / Q000627:therapeutic use*; D008113:Liver Neoplasms / Q000628:therapy*; D008297:Male; D009367:Neoplasm Staging; D012074:Remission Induction; D012189:Retrospective Studies; D015996:Survival Rate; D014014:Tissue Adhesives / Q000627:therapeutic use*; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
chemical_list: D000180:Acrylic Resins; D003487:Cyanoacrylates; D014014:Tissue Adhesives; C421460:glubran; C496735:trisacryl gelatin microspheres; D007459:Iodized Oil; D005780:Gelatin